26.03.2021

Blueberries Medical Signs Framework Agreement with YVY Life Sciences of Uruguay

Toronto, Ontario (March 26, 2021) – Blueberries Medical Corp.

26.03.2021

Blueberries Medical Appoints Former Clever Leaves Global Head of B2B as President of Latin American Operations

 

Toronto, Ontario (February 10, 2021) – Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the appointment of José María Forero, the former Global Head of B2B of Clever Leaves Holdings Inc. (NASDAQ: CLVR) (“Clever Leaves”) as President of Latin American Operations, effective February 16, 2021. 

26.10.2020

Blueberries Medical Announces Approval of Nine Psychoactive Strains, Corporate Update

TORONTO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products announced today that the Company received approval from the Colombian Agricultural Institute (“ICA”) for the registration of its nine psychoactive Tetrahydrocannabinol (“THC”) dominant strains with the national cultivar registry.

21.07.2020

Innovative Cannabis Producer Gets Big Investment from Big-time Investor

Investors in both the adult-use / recreational cannabis space, along with the medical-hemp-CBD side of the sector are Click to enlargebeginning to realize one big thing, the industry as a whole has become stagnant and cash-poor, and is in desperate need of a kickstart. That’s why savvy investors are looking for companies thinking outside of the box. Or, the fruit basket, if you will.

16.07.2020

Blueberries Announces Strategic Investor & Closing of $1.0 Million Financing

TORONTO, July 16, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce it has closed a non-brokered private placement offering (the “Offering”) of C$1,000,000 in principal amount of unsecured convertible debentures (the “Debentures”). The financing included a strategic investment by Mr.

23.06.2020

Top Value Colombian Cannabis Stock: Growing Sales, Extraction

A Latin American licensed producer of medicinal cannabis and cannabis-derived products, Blueberries Medical Corp. (CSE: BBMOTC: BBRRFFRA: 1OA, Forumoperates mainly out of the Bogotá Savannah of central Colombia.

23.04.2020

Blueberries Medical Granted Cultivation License for up to 37 Acres of Outdoor Production at Second Cultivation Property, Signs Letter of Intent to Commence Low-Cost Outdoor Production

TORONTO, April 23, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Ministry of Justice and Law of the Republic of Colombia has granted a non-psychoactive cultivation license for the  Zipaquira property, making it the Company’s second fully licensed cultivation facility in Colombia. 

01.04.2020

Blueberries Medical Provides Corporate Update

TORONTO, April 01, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries”), a Latin American producer of medicinal cannabis and cannabis-derived products, is providing the following update on the Company’s recent operating activities.

09.03.2020

Blueberries Medical Corp 2020 At Blueberries,

our number one priority is execution. As we celebrate a year since we got listed on February 6, we are proud to share with you this video which features all we have built and accomplished thus far.

06.02.2020

Blueberries Medical Commissions First Line at Extraction Facility; Secures Supply Agreements with Contract Growers; Further Strengthens Management Team

TORONTO, Feb. 06, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to provide the following update on the Company’s recent significant operational achievements:

Subscribe to News